Because obesity is so difficult to treat, the introduction of GLP-1 receptor agonists marked an important inflection point in management
Four clinical trials were conducted between 2008 and 2012 (identifier: NCT00677248, NTC00776321, NCT00593047, and NCT01410383)
GLP-1s are also sometimes used alongside other medications as part of broader blood sugar management, but the interaction between cannabis and GLP-1 medications in this area is still not well understood
The dosing schedule for Wegovy (semaglutide) involves a gradual increase in the dose over the first four weeks of treatment
Four units of Nasacort were tested at Next Breath, LLC (Baltimore, MD, USA) to characterize the in vitro spray performance
performed the electronic medical record review, collected the data, and wrote the abstract